Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Anil Chandraker, MD
Brigham and Women's Hospital/Harvard
Study Chair - Mohamed Sayegh, MD
Brigham and Women's Hospital/Harvard
Principal Investigator - Randall Starling, MD
The Cleveland Clinic
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
24 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cedars Sinai Heart Institute
Beverly Hills, California, United States
- Ronald Regan Ucla Medical Center
Los Angeles, California, United States
- Stanford University/palo Alto Va
Palo Alto, California, United States
- University of California San Francisco
San Francisco, California, United States
- Stanford University
Stanford, California, United States
- Northwestern University
Chicago, Illinois, United States
- University of Maryland
Baltimore, Maryland, United States
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Tufts Medical Center
Boston, Massachusetts, United States
- Minneapolis Heart Institute
Minneapolis, Minnesota, United States
- University of Minnesota
Minneapolis, Minnesota, United States
- Columbia University Medical Center
New York, New York, United States
- Mount Sinai School of Medicine
New York, New York, United States
- Cleveland Clinic Foundation
Cleveland, Ohio, United States
- Drexel University College of Medicine
Philadelphia, Pennsylvania, United States
- University of Pennsylvania
Philadelphia, Pennsylvania, United States
- Allegheny General Hospital
Pittsburgh, Pennsylvania, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- Medical City Dallas Hospital/crsti
Dallas, Texas, United States
- the Methodist Hospital
Houston, Texas, United States
- Intermountain Medical Center
Murray, Utah, United States
- University of Utah
Salt Lake City, Utah, United States
- University of Wisconsin
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2011
- Primary completion
- 31 Oct 2015
- Completion
- 31 Oct 2015
- Last update posted
- 25 Aug 2020
- Registered enrollment
- 362
- Registry id
- NCT01278745
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.